– Treatment of newly diagnosed diabetes patients in adulthood, with or without overweight and when dietary management is unsuccessful.
– As a combination therapy in patients who are unresponsive tor primar or secondary sulfonylurea monotherapy
– As adjunctive therapy to reduce doses, if needed.